Ziextenzo

Indicated For

neutropenia

About This Medication

# Sandoz Patient Assistance Program Patient Guide: How to Get Ziextenzo at Low or No Cost ## About Ziextenzo Ziextenzo (pegfilgrastim-bmez) is a biosimilar medication used to help prevent infections in cancer patients undergoing chemotherapy. It works by stimulating the body's production of white blood cells, which help fight infection. This medication is typically given as an injection and is an important part of cancer treatment support. ## Who Qualifies for This Program The Sandoz Patient Assistance Program is designed to help patients who cannot afford their medications. You may qualify if you: - Are a U.S. resident or Puerto Rico resident - Have a valid prescription for Ziextenzo from your healthcare provider - Meet specific income requirements (see Income Eligibility section below) - Have limited or no prescription drug coverage - Are uninsured or underinsured This program is available for patients with commercial insurance who need co-pay assistance, as well as uninsured and underinsured patients who may receive medication at reduced or no cost. ## Income Eligibility The Sandoz Patient Assistance Program uses income guidelines to determine eligibility, though specific income thresholds are not publicly disclosed. Generally, the program considers: | Household Size | Consideration | |---|---| | Individual | Income-based evaluation | | Couple (2 people) | Combined income assessment | | Family of 3 | Household income review | | Family of 4+ | Household income review | The program evaluates your financial situation based on your household income and existing insurance coverage. If you have limited or no insurance and meet the program's income guidelines, you may qualify for assistance. Contact the program directly at **(800) 277-2254** to discuss your specific financial situation—representatives can provide guidance on whether you likely qualify. ## Insurance Requirements You may be eligible if you fall into one of these categories: - **Uninsured**: You have no health insurance coverage - **Underinsured**: You have health insurance but limited or no prescription drug coverage - **Commercially insured with high co-pays**: You have commercial insurance and qualify for the co-pay assistance program **Important**: This program is designed for patients without government insurance (Medicare, Medicaid) as their primary coverage. If you have Medicare or Medicaid, you may not be eligible for this particular assistance program, though other resources may be available. ## Step-by-Step Application Process ### Step 1: Gather Required Documents Before applying, collect the following documents: - **Proof of income**: Recent tax return, pay stubs, or benefit statements - **Proof of residency**: Utility bill, lease agreement, or government-issued ID - **Valid prescription**: From your oncologist or healthcare provider for Ziextenzo - **Proof of insurance status**: Insurance card (if applicable) or documentation showing you are uninsured ### Step 2: Contact the Program Reach out to the Sandoz Patient Assistance Program in one of these ways: - **Phone**: Call **(800) 277-2254** Monday through Friday, 8 AM to 8 PM ET - **Mail**: Request an application form by phone - **Online**: Ask about online enrollment options when you call A program representative will answer your questions and help determine if you qualify. ### Step 3: Complete the Application You or your healthcare provider can complete the application. The form will ask for: - Your personal information (name, date of birth, address) - Household income details - Current insurance information - Your prescription details - Contact information Your healthcare provider must sign and date the application (electronic signature is acceptable). ### Step 4: Submit Your Application Submit your completed application along with required documents by: - **Phone**: Provide information verbally to a program representative - **Mail**: Send the form and documents to the address provided by the program - **Online**: Upload documents through the program's online portal if available ### Step 5: Await Approval The program will review your application and contact you with a decision. Once approved, you'll receive information about how your medication will be delivered. ## Timeline and Medication Delivery While specific processing times are not publicly disclosed, most patient assistance programs typically process applications within 5-10 business days. Once approved, Ziextenzo will be shipped directly to you or your physician's office, depending on your preference and the program's standard procedures. Your approval is not permanent—you will need to reauthorize your assistance periodically (typically annually) to continue receiving support. The program will notify you when reauthorization is needed. ## What If Your Application Is Denied If you don't qualify for the Sandoz Patient Assistance Program, consider these alternatives: - **Biosimilar alternatives**: Ask your oncologist about Zarxio (filgrastim-sndz) or Neulasta (pegfilgrastim), which may have their own patient assistance programs - **Manufacturer programs**: Other pharmaceutical companies offer similar assistance programs - **Non-profit organizations**: Cancer support organizations and patient advocacy groups often provide medication assistance - **Hospital financial assistance**: Your treatment facility may have programs to help with medication costs - **State pharmaceutical assistance programs**: Many states offer programs for uninsured or low-income residents ## Important Disclaimer This guide provides general information about the Sandoz Patient Assistance Program for Ziextenzo. Program eligibility, requirements, and benefits may change. Income thresholds and specific program details are not publicly disclosed and should be confirmed directly with the program. Always verify current program requirements by calling **(800) 277-2254** or consulting with your healthcare provider. This information is not a guarantee of eligibility or approval.

Program information last verified: March 30, 2026